Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BioSig Technologies Inc. Announces Proposed Public Offering
-
Applied Therapeutics Reports Second Quarter 2025 Financial Results
-
Mobix Labs Posts Record Margin, Strong Gross Profit Growth, and Major Operating Gains in Third Quarter 2025
-
Bird Announces 2025 Second Quarter Results; Delivers Strong Margin Accretion and Record Backlog
-
Wesdome Reports Second Quarter 2025 Financial Results
-
Copa Holdings Announces Monthly Traffic Statistics for July 2025
-
Labrador Gold Sets Date for Annual Meeting
-
PharmaCorp Rx Inc. Announces New Credit Facilities With CIBC and Unveils Pharmacist Co-Ownership Financing Initiative
-
North American Construction Group Ltd. Announces Results for the Second Quarter Ended June 30, 2025
-
D-BOX Confirms Naveen Prasad as President and CEO and Announces Leadership Realignment to Accelerate Growth and Execution
-
Mattr Announces Second Quarter 2025 Results
-
Quorum Announces Q2 2025 Results Release Date, Conference Call and Webcast Details
-
D-BOX Reports Record Royalty Revenues and $2.0 Million Net Profit in First Quarter Fiscal 2026
-
Stantec reports second quarter 2025 results, delivering over 20% growth in adjusted earnings per share and increases its 2025 outlook
-
Stardust Power Announces Q2 2025 Financial Results
-
Precipio Announces its Q2-2025 Financial Results
-
Orchid Island Capital Announces August 2025 Monthly Dividend and July 31, 2025 RMBS Portfolio Characteristics
-
LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the Second Quarter Ended June 30, 2025
-
Newsweek and Plant-A Insights Group Announce America’s Greatest Companies 2025
-
Brookfield Corporation Announces Pricing of $650 Million Notes Due 2036
-
Astrotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference in September 2025
-
Gulf Resources, Inc. Announces Second Quarter 2025 Unaudited Financial Results
-
rYojbaba Co., Ltd. Announces Pricing of $5 Million Initial Public Offering of Japanese Common Shares and Listing on Nasdaq
-
2025 Winners of the 31st-Annual Eric Dostie Memorial College Scholarship Announced
-
Global Water Resources Reports Second Quarter 2025 Results
-
XWELL, Inc. to Report Second Quarter 2025 Results on Thursday, August 14, 2025
-
Planet 13 Announces Q2 2025 Financial Results
-
SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update
-
Aptose Reports Second Quarter 2025 Results
-
Onco360 adds Modeyso™ (dordaviprone) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider
-
KinderCare Learning Companies, Inc. Shareholders Who Lost Money on Their Investment are Encouraged to Contact Johnson Fistel about the Class Action Lawsuit
-
Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results
-
Crescent Capital BDC, Inc. Reports Second Quarter 2025 Earnings Results; Declares a Third Quarter Base Dividend of $0.42 Per Share
-
Orezone Gold Reports Second Quarter 2025 Results
-
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
-
Henry Fernandez Steps Down from Royalty Pharma's Board of Directors
-
Caliber Reports Second Quarter 2025 Results
-
Dillard’s, Inc. to Report Second Quarter and Year-to-Date Results
-
Faraday Future Announces Second Quarter 2025 Earnings Release Date and Conference Call Details, Launching Countdown Campaign for its Dual-flywheel & Dual-bridge Eco Strategy Unveiling
-
Kelso Technologies Inc. Announces Director Retirement
-
Faraday Future Announces Second Quarter 2025 Earnings Release Date and Conference Call Details, Launching Countdown Campaign for its Dual-flywheel & Dual-bridge Eco Strategy Unveiling
-
Henry Fernandez Steps Down from Royalty Pharma's Board of Directors
-
KBR Awarded an Estimated $2.459 Billion Contract to Support Astronaut Health and Performance for Space Missions
-
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
-
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
-
FIGX Capital Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 18, 2025
-
60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results
-
Table Trac, Inc. Reports 2025 Second Quarter Earnings


